BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 23547785)

  • 1. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
    Vandooren J; Van den Steen PE; Opdenakker G
    Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
    Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
    Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase B functions as regulator and effector in leukocyte biology.
    Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
    J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.
    Martens E; Leyssen A; Van Aelst I; Fiten P; Piccard H; Hu J; Descamps FJ; Van den Steen PE; Proost P; Van Damme J; Liuzzi GM; Riccio P; Polverini E; Opdenakker G
    Biochim Biophys Acta; 2007 Feb; 1770(2):178-86. PubMed ID: 17137715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
    Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
    FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3.
    Geurts N; Becker-Pauly C; Martens E; Proost P; Van den Steen PE; Stöcker W; Opdenakker G
    FEBS Lett; 2012 Dec; 586(24):4264-9. PubMed ID: 23123160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
    Cauwe B; Martens E; Proost P; Opdenakker G
    Integr Biol (Camb); 2009 Jun; 1(5-6):404-26. PubMed ID: 20023747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isolation, characterization, and molecular cloning of a 75-kDa gelatinase B-like enzyme, a member of the matrix metalloproteinase (MMP) family. An avian enzyme that is MMP-9-like in its cell expression pattern but diverges from mammalian gelatinase B in sequence and biochemical properties.
    Hahn-Dantona EA; Aimes RT; Quigley JP
    J Biol Chem; 2000 Dec; 275(52):40827-38. PubMed ID: 11010969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).
    Van den Steen PE; Dubois B; Nelissen I; Rudd PM; Dwek RA; Opdenakker G
    Crit Rev Biochem Mol Biol; 2002 Dec; 37(6):375-536. PubMed ID: 12540195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
    Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
    Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.
    Rosenblum G; Van den Steen PE; Cohen SR; Grossmann JG; Frenkel J; Sertchook R; Slack N; Strange RW; Opdenakker G; Sagi I
    Structure; 2007 Oct; 15(10):1227-36. PubMed ID: 17937912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B.
    Gioia M; Monaco S; Van Den Steen PE; Sbardella D; Grasso G; Marini S; Overall CM; Opdenakker G; Coletta M
    J Mol Biol; 2009 Feb; 386(2):419-34. PubMed ID: 19109975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
    Warner RL; Beltran L; Younkin EM; Lewis CS; Weiss SJ; Varani J; Johnson KJ
    Am J Respir Cell Mol Biol; 2001 May; 24(5):537-44. PubMed ID: 11350822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the roles of extracellular matrix remodeling by gelatinase B.
    Opdenakker G
    Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
    Rowsell S; Hawtin P; Minshull CA; Jepson H; Brockbank SM; Barratt DG; Slater AM; McPheat WL; Waterson D; Henney AM; Pauptit RA
    J Mol Biol; 2002 May; 319(1):173-81. PubMed ID: 12051944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
    Khan MM; Simizu S; Suzuki T; Masuda A; Kawatani M; Muroi M; Dohmae N; Osada H
    Exp Cell Res; 2012 May; 318(8):904-14. PubMed ID: 22406264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock.
    Hu J; Van den Steen PE; Dillen C; Opdenakker G
    Biochem Pharmacol; 2005 Aug; 70(4):535-44. PubMed ID: 15992779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes.
    Descamps FJ; Martens E; Ballaux F; Geboes K; Opdenakker G
    J Pathol; 2004 Dec; 204(5):555-61. PubMed ID: 15538738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.
    Scannevin RH; Alexander R; Haarlander TM; Burke SL; Singer M; Huo C; Zhang YM; Maguire D; Spurlino J; Deckman I; Carroll KI; Lewandowski F; Devine E; Dzordzorme K; Tounge B; Milligan C; Bayoumy S; Williams R; Schalk-Hihi C; Leonard K; Jackson P; Todd M; Kuo LC; Rhodes KJ
    J Biol Chem; 2017 Oct; 292(43):17963-17974. PubMed ID: 28860188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.